Application of a clinical decision support tool for predicting biochemical remission with vedolizumab therapy in patients with ulcerative colitis

被引：0
|
作者：
Kim, Kyuwon [1 ]
Oh, Kyunghwan [1 ]
Hong, Hee Seung [1 ]
Lee, Jae Yong [1 ]
Hong, Seung Wook [1 ]
Park, Jin Hwa [1 ]
Hwang, Sung Wook [1 ,2 ]
Park, Sang Hyoung [1 ,2 ]
Yang, Dong-Hoon [1 ]
Byeon, Jeong-Sik [1 ]
Myung, Seung-Jae [1 ]
Yang, Suk-Kyun [1 ,2 ]
Ye, Byong Duk [1 ,2 ]
机构：
[1] Univ Ulsan, Dept Gastroenterol, Coll Med, Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Inflammatory Bowel Dis Ctr, Coll Med, Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷
关键词：
biochemical remission; clinical decision support tool; ulcerative colitis; vedolizumab;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP-0484
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [21] Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis
    Dulai, Parambir S.
    Singh, Siddharth
    Casteele, Niels Vande
    Meserve, Joseph
    Winters, Adam
    Chablaney, Shreya
    Aniwan, Satimai
    Shashi, Preeti
    Kochhar, Gursimran
    Weiss, Aaron
    Koliani-Pace, Jenna L.
    Gao, Youran
    Boland, Brigid S.
    Chang, John T.
    Faleck, David
    Hirten, Robert
    Ungaro, Ryan
    Lukin, Dana
    Sultan, Keith
    Hudesman, David
    Chang, Shannon
    Bohm, Matthew
    Varma, Sashidhar
    Fischer, Monika
    Shmidt, Eugenia
    Swaminath, Arun
    Gupta, Nitin
    Rosario, Maria
    Jairath, Vipul
    Guizzetti, Leonardo
    Feagan, Brian G.
    Siegel, Corey A.
    Shen, Bo
    Kane, Sunanda
    Loftus, Edward V., Jr.
    Sandborn, William J.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Lasch, Karen
    Cao, Charlie
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (13) : 2952 - +
  • [22] Clinical decision support improves quality of care in patients with ulcerative colitis
    Jackson, Belinda
    Begun, Jake
    Gray, Kathleen
    Churilov, Leonid
    Liew, Danny
    Knowles, Simon
    De Cruz, Peter
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (08) : 1040 - 1051
  • [23] Clinical decision support improves quality of care for patients with ulcerative colitis
    Jackson, B. D.
    Begun, J.
    Gray, K.
    Liew, D.
    Knowles, S.
    De Cruz, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 96 - 96
  • [24] Maintenance therapy of vedolizumab (VDZ) after induction of remission by tacrolimus (TAC) in patients with refractory ulcerative colitis (UC)
    Ito, A.
    Shun, M.
    Teppei, O.
    Katsutoshi, T.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S377 - S378
  • [25] Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on Vedolizumab
    Chaemsupaphan, Thanaboon
    Pudipeddi, Aviv
    Lin, Huiyu
    Paramsothy, Sudarshan
    Kariyawasam, Viraj
    Kermeen, Melissa
    Leong, Rupert W.
    CROHNS & COLITIS 360, 2025, 7 (01)
  • [26] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
  • [27] COMBINATION THERAPY DOES NOT IMPROVE CLINICAL AND ENDOSCOPIC REMISSION RATES WITH VEDOLIZUMAB OR USTEKINUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS
    Hu, Anne
    Kotze, Paulo G.
    Tan, William
    Jess, Alison T.
    Li, Pei-Shun Mimi
    Kroeker, Karen I.
    Halloran, Brendan P.
    Panaccione, Remo
    Ma, Christopher
    Ananthakrishnan, Ashwin
    GASTROENTEROLOGY, 2020, 158 (06) : S53 - S53
  • [28] Calprotectin at week 12 is a predictor for histological remission in ulcerative colitis patients treated with Vedolizumab
    Rubstov, D.
    Ramaswamy, P. Kakkadasam
    Edwards, J.
    Shukla, D.
    Willmann, L.
    Moattar, H.
    Bhullar, M.
    Ishaq, N.
    Dorrington, A.
    Mohsen, W.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S515 - S516
  • [29] Response and Remission Rates With up to 3 Years of Vedolizumab Treatment in Patients with Ulcerative Colitis
    Loftus, Edward V.
    Colombel, Jean-Frederic
    Previtali, Alessandro
    Smyth, Michael D.
    GASTROENTEROLOGY, 2016, 150 (04) : S805 - S805
  • [30] Characteristics of Patients With Ulcerative Colitis Initiating Vedolizumab Therapy in Real-World Clinical Practice
    Khalid, Javaria M.
    Reynolds, Matthew
    Alam, Naufi L.
    Don, O'Hara
    Smyth, Michael D. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S825 - S825
12345